Skip to main content
HR 2916 117th Congress House Armed Forces and National Security Alternative treatments Congressional oversight Drug trafficking and controlled substances Government studies and investigations Health information and medical records Medical research Mental health Neurological disorders Veterans' medical care

VA Medicinal Cannabis Research Act of 2021

Introduced: April 30, 2021 Introduced by: Correa, J. Luis Democratic · California See on congress.gov
 Everywhere this bill has been 8 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 4, 2021
Ordered to be Reported by the Yeas and Nays: 18 - 11.
Nov 4, 2021
Committee Consideration and Mark-up Session Held.
Nov 4, 2021
Subcommittee on Health Discharged.
Oct 14, 2021
Subcommittee Hearings Held.
Jul 14, 2021
Referred to the Subcommittee on Health.
Apr 30, 2021
Referred to the House Committee on Veterans' Affairs.
Apr 30, 2021
Sponsor introductory remarks on measure. (CR E470)
Apr 30, 2021
Introduced in House
 Plain-English summary Congressional Research Service

VA Medicinal Cannabis Research Act of 2021

This bill requires the Department of Veterans Affairs (VA) to conduct clinical trials of the effects of medical-grade cannabis on the health outcomes of covered veterans diagnosed with chronic pain and those diagnosed with post-traumatic stress disorder. Covered veterans are those who are enrolled in the VA health care system.

The trials must include a control group and an experimental group that are of similar sizes and structures and represent the demographics of the veteran population.

Data collected in the trials must be preserved to facilitate further research.

Under the bill, participation in the clinical trials does not affect a covered veteran's eligibility or entitlement to other VA benefits.

What's happening now November 4, 2021

Ordered to be Reported by the Yeas and Nays: 18 - 11.

 Committees of jurisdiction 2